>
Switch to:

Corcept Therapeutics Non Operating Income

: $0.0 Mil (TTM As of Dec. 2020)
View and export this data going back to 2004. Start your Free Trial

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Corcept Therapeutics's non-recurring items for the three months ended in Dec. 2020 was $0.0 Mil. Its non-recurring items for the trailing twelve months (TTM) ended in Dec. 2020 was $0.0 Mil.

As of today (2021-04-12), Corcept Therapeutics's share price is $22.430000. Corcept Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2020 was $0.85. Therefore, Corcept Therapeutics's PE Ratio without NRI ratio for today is 26.39.

Corcept Therapeutics Non Operating Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

* Premium members only.

Corcept Therapeutics Annual Data
Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Corcept Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Corcept Therapeutics Non Operating Income Calculation

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Examples of NRI include gains (losses) from plant shutdown, lease-breaking fees, lawsuit, write-offs, write-downs, restructuring costs or sales of an investment, discontinued operations etc.

NRI can impact a company's reported income drastically.

Non Operating Income for the trailing twelve months (TTM) ended in Dec. 2020 was 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) + 0 (Dec. 2020 ) = $0.0 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

GuruFocus lists a PE Ratio without NRI, which is the price/earnings before NRI. We believe it more accurately reflects the valuation of the company.

Corcept Therapeutics's PE Ratio without NRI Ratio for today is calculated as

PE Ratio without NRI=Share Price/EPS without NRI
=22.430000/0.85
=26.39

Corcept Therapeutics's Share Price of today is $22.430000.
Corcept Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2020 was 0.25 (Mar. 2020 ) + 0.23 (Jun. 2020 ) + 0.17 (Sep. 2020 ) + 0.2 (Dec. 2020 ) = $0.85.

* All numbers are in millions except for per share data and ratio. All numbers are indicated in the company's associated stock exchange currency.

Corcept Therapeutics Non Operating Income Related Terms

Corcept Therapeutics Non Operating Income Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)